Retention in Care Clinical Trials
3 recruiting trials for Retention in Care. Eligibility criteria explained in plain English.
TrialFinderData lists 3 Retention in Care clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by University of Maryland, College Park (1), Karolinska Institutet (1), Johns Hopkins University (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Peer-Delivered Behavioral Activation ("Peer Activate") (behavioral, 1 trial), followed by Co-produced intervention to optimize PMTCT care engagement, Full-SPARCS Intervention.
Track Retention in Care trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Peer Recovery to Improve Polysubstance Use and Mobile Telemedicine Retention
The purpose of this study is to evaluate the feasibility and effectiveness of a peer-led, brief, behavioral intervention to improve adherence to medication for opioid use disorder...
Optimizing Prevention and Care for Pregnant and Postpartum Adolescent Girls and Young Women With HIV in Tanzania
The goal of this clinical trial is to find better ways to care for pregnant and postpartum adolescent girls and young women (AGYW) aged 15-24 years with HIV in Tanzania, and to...
Structured Peer-delivered ART and Reentry Community Strategy
The overarching goal of this study is to implement a transition community adherence club strategy (Full-SPARCS) for HIV-positive individuals transitioning from correctional to...
Explore Other Conditions
Frequently Asked Questions
There are currently 3 clinical trials for Retention in Care, with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Retention in Care, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Retention in Care, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.